 Product Search |
|
| Input Product Name Or Cas No. |
| Category |
| Products |
 (4-hydroxy-3,5-dimethylphenyl)diphenylsu |
| 4-[[(Trifluoromethyl)sulfonyl]oxy]cycloh |
| 6-Bromo-8-methoxyimidazo[1,2-a]pyridine |
| 5-Bromo-2-chloro-3-ethylpyridine |
| 6-(6-Chloro-5-ethyl-3-pyridinyl)-8-methy |
| 2-Pyridinamine, 3-bromo-6-chloro-N,N-dim |
| 6-(3,5-Dimethyl-4-isoxazolyl)-1-(di-2-py |
| 5-Bromo-2-methoxy-N-(6-methoxy-3-methyl- |
| 2-methoxy-4-(3-(phenylamino)imidazo[1,2- |
| 1-cyclopropyl-3-(2-(4,5-dibromo-2H-1,2,3 |
| (6-chloro-5-methylpyridazin-3-yl)(pyridi |
| (6-chloro-4-methylpyridazin-3-yl)(pyridi |
| (6-chloro-5-methylpyridazin-3-yl)(pyridi |
| 1,2,4-Triazine, 3,5-dichloro-6-[2-methox |
| 6-Bromo-3-fluoro-1H-indole |
| 1,1-Dimethylethyl 3-[1-(4,4,5,5-tetramet |
| 6,7-Dihydro-4H-furo[3,2-c]azepine-4,8(5H |
| 6-(2-methoxy-4-(trifluoromethyl)phenyl)- |
| (6-Chloro-4,5-dimethyl-3-pyridazinyl)-3- |
| 2-Bromo-3-methoxy-5-(trifluoromethyl)pyr |
| (6-Chloro-3-pyridazinyl)-3-pyridinylmeth |
| Boronic acid, B-[5-fluoro-2-methoxy-4-(t |
| 6-bromo-3-fluoro-1-tosyl-1H-indole |
| 3-fluoro-6-(4,4,5,5-tetramethyl-1,3,2-di |
| 1-Phenylcyclohexyl 4-ethenylbenzoate |
| 3,4-Dihydro-2H-1-benzopyran-4-yl 2-methy |
| 1-(2-Methoxy-1-methylethyl)cyclopentyl 2 |
| 1-Ethyl-2,3-dihydro-1H-inden-1-yl 2-meth |
| 1-Methyl-2-methylenecyclopentyl 2-methyl |
| 9-Methyl-9H-fluoren-9-yl 2-methyl-2-prop |
| Sulfonium, triphenyl-, 9,10-dihydro-9,10 |
| Sulfonium, triphenyl-, 9,10-dihydro-9,10 |
| 1,1-Dimethylethyl 2-(3-bromophenyl)-5-ch |
| 6-bromo-7-methoxy-1-(4-methoxybenzyl)-1H |
| 6-bromo-7-methoxy-1-(tetrahydro-2H-pyran |
| ethyl 4-chloro-6-(cyclopropanecarboxamid |
| Methyl 2-(3-bromophenyl)-7-hydroxy-5-met |
| 1,1-Dimethylethyl 2-(3-bromophenyl)-5-ch |
| methyl 4-amino-6-(cyclopropanecarboxamid |
| methyl 4-amino-6-(cyclopropanecarboxamid |
| methyl 6-(cyclopropanecarboxamido)-4-((4 |
| 1-(tert-butyl) 3-methyl 2-(6-chloro-5-me |
| methyl 2-(6-((2,4-dimethoxybenzyl)amino) |
| 4-chloro-6-(cyclopropanecarboxamido)nico |
| methyl 4-chloro-6-(cyclopropanecarboxami |
| Methyl 2-[(3-methyl-1H-pyrrol-2-yl)carbo |
| tert-butyl 4-(allyloxy)-4-methylpiperidi |
| 4-Chloro-6-(1-fluoro-1-methylethyl)-1,3, |
| 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborola |
| 1-(1,1-Dimethylethyl) 4-methyl 4-(3-bute |
|
| Products |
| Catalogue Number |
Products |
CAS No. |
Assay |
| RovathinS30684 | 1-(Diphenylmethyl)-3-(hydroxymethyl)azetidine | 72351-36-1 | 95% |
| RovathinS30685 | Enoximone | 77671-31-9 | 95% |
| RovathinS30686 | Methanesulfonamide, N-(5-methoxy-2-phenoxyphenyl)- | 123664-84-6 | 95% |
| RovathinS30687 | 5-(2-furyl)-1,3,4-oxadiazol-2-amine | 7659-06-5 | 95% |
| RovathinS30688 | 4-chloro-2,6-bis(5-chloro-2-hydroxybenzyl)phenol | 6642-07-5 | 95% |
| RovathinS30689 | Iguratimod | 123663-49-0 | 95% |
| RovathinS30690 | Alfuzosin hydrochloride | 81403-68-1 | 95% |
| RovathinS30691 | 5-Pyrimidinecarboxylic acid, 1,2,3,4-tetrahydro-2,4-dioxo- | 23945-44-0 | 95% |
| RovathinS30692 | Benzenemethanamine, 2,3-dichloro-N-cyclopropyl- | 625437-42-5 | 95% |
| RovathinS30693 | Formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) | 200815-49-2 | 95% |
| RovathinS30694 | Formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, (2R,3R)- | 67346-49-0 | 95% |
| RovathinS30695 | 1H-Indole, 3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-, hydrobromide (1:1) | 177834-92-3 | 95% |
| RovathinS30696 | 1H-Indole, 3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]- | 143322-58-1 | 95% |
| RovathinS30697 | 1H-Inden-1-amine, 2,3-dihydro-N-2-propyn-1-yl-, (1R)-, methanesulfonate (1:1) | 161735-79-1 | 95% |
| RovathinS30698 | Acetic acid, 2-(1-methyl-4-piperidinylidene)-, methyl ester | 154594-25-9 | 95% |
| RovathinS30699 | 1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, hydrochloride | 143388-64-1 | 95% |
| RovathinS30700 | Methanesulfonamide, N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]- | 141626-36-0 | 95% |
| RovathinS30701 | Methanesulfonamide, N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]-, hydrochloride | 141625-93-6 | 95% |
| RovathinS30702 | Acetamide, N-[2-(7-methoxy-1-naphthalenyl)ethyl]- | 138112-76-2 | 95% |
| RovathinS30703 | 9-Azabicyclo[3.3.1]nonan-3-amine, 9-methyl-, hydrochloride (1:2), (3-endo)- | 135906-03-5 | 95% |
| RovathinS30704 | Benzeneacetic acid, 2-amino-3-(4-bromobenzoyl)-, sodium salt, hydrate (2:2:3) | 120638-55-3 | 95% |
| RovathinS30705 | 1H-Indazole-3-carboxamide, 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]- | 109889-09-0 | 95% |
| RovathinS30706 | 2-Propanol, 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-, (2E)-2-butenedioate (2:1) | 104344-23-2 | 95% |
| RovathinS30707 | 3,5-Pyridinedicarboxylic acid, 4-[2-[(1E)-3-(1,1-dimethylethoxy)-3-oxo-1-propen-1-yl]phenyl]-1,4-dihydro-2,6-dimethyl-, 3,5-diethyl ester | 103890-78-4 | 95% |
| RovathinS30708 | Ethanamine, 2-[4-[(1Z)-4-chloro-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) | 89778-27-8 | 95% |
| RovathinS30709 | 3-Pyridinecarboxylic acid, 2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-5-(hydroxymethyl)- | 81335-78-6 | 95% |
| RovathinS30710 | Morpholine, 4-[3-[4-(1,1-dimethylpropyl)phenyl]-2-methylpropyl]-2,6-dimethyl-, hydrochloride (1:1), (2R,6S)-rel- | 78613-38-4 | 95% |
| RovathinS30711 | 9-Azabicyclo[3.3.1]nonan-3-amine, 9-methyl-, (3-endo)- | 76272-56-5 | 95% |
| RovathinS30712 | Carbamic acid, N-[2-amino-6-[[(4-fluorophenyl)methyl]amino]-3-pyridinyl]-, ethyl ester, (2Z)-2-butenedioate (1:1) | 75507-68-5 | 95% |
| RovathinS30713 | [2,2'-Bipyridine]-4,4'-dicarboxylic acid, 4,4'-dibutyl ester | 69641-93-6 | 95% |
|
|
|
|
